Literature DB >> 14872509

Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin.

Udo S Gaipl1, Thomas D Beyer, Petra Heyder, Susanne Kuenkele, Andrea Böttcher, Reinhard E Voll, Joachim R Kalden, Martin Herrmann.   

Abstract

OBJECTIVE: The efficient uptake of dying cells by phagocytes is essential to the avoidance of chronic inflammation. Some human autoimmune responses are thought to be driven by autoantigens from apoptotic or necrotic cells. We analyzed the role of C1q and DNase I in the disposal of necrotic cell-derived chromatin because deficiencies in these serum factors predispose to the development of systemic autoimmune disorders, such as systemic lupus erythematosus.
METHODS: Human necrotic peripheral blood lymphocytes were incubated in cell culture medium supplemented with various sera or serum components. Chromatin degradation was monitored by measuring the residual DNA content by flow cytometry. The uptake of necrotic cell-derived nuclei was analyzed by in vitro phagocytosis assays.
RESULTS: Reconstitution of C1q-depleted serum with C1q strongly increased its ability to degrade necrotic cell-derived chromatin. Although C1q itself displayed no DNase activity, it strongly augmented the activity of serum DNase I. Whereas an excess of recombinant DNase I degraded chromatin in the absence of C1q, efficient uptake of the predigested material by monocyte-derived phagocytes required the presence of C1q. These data show that C1q and DNase I cooperate in the degradation of chromatin from necrotic cells. Furthermore, C1q was found to be necessary for effective uptake of degraded chromatin by monocyte-derived phagocytes.
CONCLUSION: C1q or DNase I deficiencies may precipitate autoimmunity in humans by a mechanism similar to that of other molecules that are involved in the safe, efficient, and rapid disposal of dying cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872509     DOI: 10.1002/art.20034

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

Review 1.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 2.  Extracellular traps and macrophages: new roles for the versatile phagocyte.

Authors:  Devin M Boe; Brenda J Curtis; Michael M Chen; Jill A Ippolito; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2015-04-15       Impact factor: 4.962

3.  [An impaired detection and clearance of dying cells can lead to the development of chronic autoimmunity].

Authors:  L E Munoz; M Herrmann; U S Gaipl
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

Review 4.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

Review 5.  New insights into the immunopathogenesis of systemic lupus erythematosus.

Authors:  George C Tsokos; Mindy S Lo; Patricia Costa Reis; Kathleen E Sullivan
Journal:  Nat Rev Rheumatol       Date:  2016-11-22       Impact factor: 20.543

Review 6.  Autoimmunity versus tolerance: can dying cells tip the balance?

Authors:  Irene C B Viorritto; Nikolay P Nikolov; Richard M Siegel
Journal:  Clin Immunol       Date:  2006-10-05       Impact factor: 3.969

7.  Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids.

Authors:  K Lauber; H Keppeler; L E Munoz; U Koppe; K Schröder; H Yamaguchi; G Krönke; S Uderhardt; S Wesselborg; C Belka; S Nagata; M Herrmann
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

Review 8.  The complement cascade as a mediator of tissue growth and regeneration.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Brian J Ahn; Shanna Fang; Andrew T Parsa
Journal:  Inflamm Res       Date:  2010-06-02       Impact factor: 4.575

Review 9.  Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.

Authors:  Hanna Kim; Gina A Montealegre Sanchez; Raphaela Goldbach-Mansky
Journal:  J Mol Med (Berl)       Date:  2016-09-27       Impact factor: 4.599

10.  DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Authors:  Fernando Martinez-Valle; Eva Balada; Josep Ordi-Ros; Segundo Bujan-Rivas; Agustin Sellas-Fernandez; Miquel Vilardell-Tarres
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.